Skip to main content
SpringerLink
Log in

Clinical Applications Targeting Periostin

  • Chapter
  • First Online:
Periostin

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 1132))

Abstract

Since periostin is expressed and functioned in incredible diseases , clinical applications have been initiated to directly target periostin for inhibition or activation, or periostin expression is utilized to indicate the disease state or a marker for curing diseases, which will provide novel methods in clinical applications.

Material in this chapter has been adapted from Kudo [10] and Kudo and Kii [11] with permission.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Bae H-S, Son H-Y, Lee JP, Chang H, Park J-U (2018) The role of periostin in capsule formation on silicone implants. Biomed Res Int 2018:1–10

    Google Scholar 

  2. Corren J, Lemanske RF, Hanania NA, Korenblat PE, Parsey MV, Arron JR et al (2011) Lebrikizumab treatment in adults with asthma. N Engl J Med 365:1088–1098

    Article  CAS  Google Scholar 

  3. Field S, Uyttenhove C, Stroobant V, Cheou P, Donckers D, Coutelier J-P, Simpson RT, Cummings MC, Saunus JM, Reid LE, Kustasovic JR, McNicol AM, Kim BR, Kim JH, Lakhani SR, Neville AM, Snick JV, Jat PS (2016) Novel highly specific anti-periostin antibodies uncover the functional importance of the fascilin 1-1 domain and highlight preferential expression of periostin in aggressive breast cancer. Int J Cancer 138:1959–1970

    Article  CAS  Google Scholar 

  4. Hoshino M, Ohtawa J, Akitsu K (2015) Effect of treatment with inhaled corticosteroid on serum periostin levels in asthma. Respirology 21:297–303

    Article  Google Scholar 

  5. Inaki R, Fujihara Y, Kudo A, Misawa M, Hikita A, Takato T, Hoshi K (2018) Periostin contributes to the maturation and shape retention of tissue-engineered cartilage. Sci Rep 8:11210

    Article  Google Scholar 

  6. Katial RK, Bensch GW, Busse WW, Chipps BE, Gerber JLCAN, Jacobs JS, Kraft M, Martin RJ, Nair P, Wechsler ME (2017) Changing paradigms in the treatment of severe asthma: the role of biologic therapies. J Allergy Clin Immunol Pract 5:S1–S14

    Article  Google Scholar 

  7. Kim BJ, Rhee Y, Kim CH, Baek KH, Min YK, Kim DY, Ahn SH, Kim H, Lee SH, Lee SY, Kang MI, Koh JM (2015) Plasma periostin associates significantly with non-vertebral but not vertebral fractures in postmenopausal women: clinical evidence for the different effects of periostin depending on the skeletal site. Bone 81:435–441

    Article  CAS  Google Scholar 

  8. Kimura T, Nojiri T, Hino J, Hosoda H, Miura K, Shintani Y, Inoue M, Zenitani M, Takabatake H, Miyazono M, Okumura M, Kangawa K (2016) C-type natriuretic peptide ameliorates pulmonary fibrosis by acting on lung fibroblasts in mice. Respir Res 17:19

    Article  Google Scholar 

  9. Kraft M (2011) Asthma phenotypes and interleukin-13--moving closer to personalized medicine. N Engl J Med 365:1141–1144

    Article  CAS  Google Scholar 

  10. Kudo A (2017) Introductory review: periostin-gene and protein structure. Cell Mol Life Sci 74:4259–4268. https://doi.org/10.1007/s00018-017-2643-5

    Article  CAS  Google Scholar 

  11. Kudo A, Kii I (2018) Periostin function in communication with extracellular matrices. J Cell Commun Signal 12:301–308. https://doi.org/10.1007/s12079-017-0422-6

    Article  Google Scholar 

  12. Lee YJ, Kim IS, Park S-A, Kim Y, Lee JE, Noh D-Y, Kim K-T, Ryu SH, Suh P-G (2013) Periostin-binding DNA adapter inhibits breast cancer growth and metastasis. Mol Ther 21:1004–1013

    Article  CAS  Google Scholar 

  13. Nakama T, Yoshida S, Ishikawa K, Kobayashi Y, Zhou Y, Nakao S, Sassa Y, Oshima Y, Takao K, Shimahara A, Yoshikawa K, Hamasaki T, Ohgi T, Hayashi H, Matsuda A, Kudo A, Nozaki M, Ogura Y, Kuroda M, Ishibashi T (2015) Inhibition of choroidal fibrovascular membrane formation by new class of RNA interference therapeutic agent targeting periostin. Gene Ther 22:127–137

    Article  Google Scholar 

  14. Nakama T, Yoshida S, Ishikawa K, Kubo Y, Kobayashi Y, Zhou Y, Nakao S, Hisatomi T, Ikeda Y, Takao K, Yoshikawa K, Matsuda A, Ono J, Ohta S, Izuhara K, Kudo A, Sonoda K, Ishibashi T (2017) Therapeutic effect of novel single-stranded RNAi agent targeting periostin in eyes with retinal neovascularization. Mol Ther Nucleic Acids 6:279–289

    Article  CAS  Google Scholar 

  15. Nam BY, Park JT, Kwon YE, Lee JP, Jung JH, Kim Y, Kim S, Park J, Um JE, Wu M, Han SH, Yoo T-H, Kang S-W (2017) Periostin-binding DNA aptamer treatment ameliorates peritoneal dialysis-induced peritoneal fibrosis. Mol Ther Nucleic Acids 17:396–407

    Article  Google Scholar 

  16. Parulekar AD, Kao CC, Diamant Z, Hanania NA (2018) Targeting the interleukin-4 and interleukin-13 pathways in severe asthma: current knowledge and future needs. Curr Opin Pulm Med 24:50–55

    Article  CAS  Google Scholar 

  17. Polizzotti BD, Arab S, Kuhn B (2012) Intrapericardial delivery of gelform enables the targeted delivery of periostin peptide after myocardial infarction by inducing fibrin clot formation. PLoS ONE 7:e36788

    Article  CAS  Google Scholar 

  18. Takai S, Yoshino M, Takao K, Yoshikawa K, Jin D (2017) Periostin antisense oligonucleotide prevents adhesion formation after surgery in mice. J Pharmacol Sci 133:30–69

    Article  Google Scholar 

  19. Taniyama Y, Katsuragi N, Sanada F, Azuma J, Iekushi K, Koibuchi N, Okayama K, Ikeda-Iwabu Y, Muratsu J, Otsu R, Rakugi H, Morishita R (2016) Selective blockade of periostin exon 17 preserves cardiac performance in acute myocadial infarction. Hypertension 67:356–361

    Article  CAS  Google Scholar 

  20. Tomaru A, Kobayashi T, Hinneh JA, Tonto PB, D’Alessandro-Gabazza CN, Fujimoto H, Fujiwara K, Takahashi Y, Ohnishi M, Yasuma T, Nishihama K, Yoshino M, Takao K, Toda M, Totoki T, Takei Y, Yoshikawa K, Taguchi O, Gabazza EC (2017) Oligonucleotide-targeting periostin ameliorates pulmonary fibrosis. Gene Ther 24:706–716

    Article  CAS  Google Scholar 

  21. Vico L, Rietbergen BV, Vilayphiou N, Linossier M-T, Locrelle H, Normand M, Zouch M, Gerbaix M, Bonnet N, Novikov V, Thomas T, Vassilieva G (2017) Cortical and trabecular bone microstructure did not recover at weight-bearing skeletal sites and progressively deteriorated at non-weight-bearing sites during the year following International Space Station missions. J Bone Miner Res 32:2010–2021

    Article  CAS  Google Scholar 

  22. Zhang T, Ma G, Zhang Y, Huo H, Zhao Y (2017) miR-599 inhibits proliferation and invasion of glioma by targeting periostin. Biotechnol Lett 39:1325–1333

    Article  CAS  Google Scholar 

  23. Zhu R, Zheng Y, Dirks NL, Vadhavkar S, Jin JY, Peng K, CTJ H, Olsson J, Matthews JG, Putnam WS (2017) Model-based clinical pharmacological profiling and exposure-response relationships of the efficacy and biomarker of lebrikizumab in patients with moderate-to-serve asthma. Pulm Pharmacol Ther 46:88–98

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. International Frontier, Tokyo Institute of Technology, Meguro-ku, Tokyo, Japan

    Akira Kudo

  2. School of Dentistry, Showa University, Tokyo, Japan

    Akira Kudo

Authors
  1. Akira Kudo
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Akira Kudo .

Editor information

Editors and Affiliations

  1. International Frontier, Tokyo Institute of Technology, Tokyo, Japan

    Akira Kudo

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Kudo, A. (2019). Clinical Applications Targeting Periostin. In: Kudo, A. (eds) Periostin. Advances in Experimental Medicine and Biology, vol 1132. Springer, Singapore. https://doi.org/10.1007/978-981-13-6657-4_19

Download citation

Publish with us

Policies and ethics

Search

Navigation